Clinical trial for COVID-19 vaccine to begin in US

(AP) -- A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.

A government official says the first participant in the trial will receive the experimental vaccine that day.

The National Institutes of Health is funding the trial that is taking place at a Kaiser Permanente research facility in Washington State.

Public health officials say it will take a year to 18 months to fully validate any potential vaccine.

Share this article: